Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Champlin

Showing results (61-70 of 217) with videos related to

Pageof 22
Sort By:
Journal of Medical Virology|August 27, 2019
Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipientsLynn El Haddad, Shashank S Ghantoji, Anne K Park, et al.
Blood|January 17, 2004
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type mattersMaha El-Zimaity, Rima Saliba, Kawah Chan, et al.
Human Immunology|July 5, 2005
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantationShraga Aviner, Xin Yao, Rita Krauthgamer, et al.
American Journal of Hematology|June 11, 2013
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilizationVeronica R Smith, Uday Popat, Stefan Ciurea, et al.
Transfusion|May 18, 2011
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantationChitra Hosing, Veronica Smith, Beverly Rhodes, et al.
The New England Journal of Medicine|October 11, 2018
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal LeukoencephalopathyMuharrem Muftuoglu, Amanda Olson, David Marin, et al.
Blood|May 6, 2003
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trialsSergio Giralt, William Bensinger, Mark Goodman, et al.
Cancer|May 2, 2013
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemiaHagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, et al.
Cancer|July 31, 2010
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding studyMarcos de Lima, Sergio Giralt, Peter F Thall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid LeukemiaLauren Veltri, Katayoun Rezvani, Betul Oran, et al.
Pageof 22

Showing results (61-70 of 217) with videos related to

Sort By:
Pageof 22
Journal of Medical Virology|August 27, 2019
Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipientsLynn El Haddad, Shashank S Ghantoji, Anne K Park, et al.
Blood|January 17, 2004
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type mattersMaha El-Zimaity, Rima Saliba, Kawah Chan, et al.
Human Immunology|July 5, 2005
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantationShraga Aviner, Xin Yao, Rita Krauthgamer, et al.
American Journal of Hematology|June 11, 2013
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilizationVeronica R Smith, Uday Popat, Stefan Ciurea, et al.
Transfusion|May 18, 2011
Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantationChitra Hosing, Veronica Smith, Beverly Rhodes, et al.
The New England Journal of Medicine|October 11, 2018
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal LeukoencephalopathyMuharrem Muftuoglu, Amanda Olson, David Marin, et al.
Blood|May 6, 2003
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trialsSergio Giralt, William Bensinger, Mark Goodman, et al.
Cancer|May 2, 2013
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemiaHagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, et al.
Cancer|July 31, 2010
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding studyMarcos de Lima, Sergio Giralt, Peter F Thall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2018
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid LeukemiaLauren Veltri, Katayoun Rezvani, Betul Oran, et al.
Pageof 22